Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
A Randomized Controlled Trial of Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
研究概览
详细说明
Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide. A subset of patients with severe COPD develops chronic hypercapnic respiratory failure, often requiring long-term home non-invasive ventilation (NIV). While NIV can improve gas exchange, optimal management strategies, particularly post-hospitalization, are still being investigated.
This study aims to determine if a proactive, remote management strategy can improve patient outcomes compared to standard care with passive monitoring.
Experimental Group (Remote Intervention): Participants will receive home NIV with remote monitoring. A respiratory therapist will actively review ventilation data, assess oxygenation, and perform remote parameter adjustments and individualized optimization based on pre-set conditions and risk predictions.
Control Group (Monitoring Control): Participants will receive home NIV with remote monitoring. However, the study team will not perform active interventions based on the monitoring data. Patients will continue with their usual care and follow-up with their primary physician. The study team will only make contact in case of a severe safety risk.
The study will enroll 236 participants who will be randomized 1:1 to one of the two groups. The primary outcomes are the change in health-related quality of life and the number of COPD exacerbations over 12 months.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Huiqing Ge, MD, PhD
- 电话号码:+86 13588706787
- 邮箱:gehq@zju.edu.cn
学习地点
-
-
Henan
-
Zhengzhou、Henan、中国
- Henan Provincial People's Hospital
-
接触:
- Qiang Kui, MD
- 电话号码:+86 13460317523
- 邮箱:syhxzzggyx@163.com
-
-
Hunan
-
Changsha、Hunan、中国、410006
- The Second Xiangya Hospital of Central South University
-
接触:
- Liucun Li
- 电话号码:+86 0731-852959999
- 邮箱:xyeyyibd@sina.com
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310016
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
-
接触:
- Huiqing Ge
- 电话号码:+86 13588706787
- 邮箱:gehq@zju.edu.cn
-
Wenling、Zhejiang、中国、317523
- Taizhou Hospital of Integrated Traditional Chinese and Western Medicine
-
接触:
- Ting Jiang
- 电话号码:+86 13758692956
- 邮箱:13758692956@139.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Meets the diagnostic criteria for Chronic Obstructive Pulmonary Disease (COPD) with confirmed persistent airflow limitation by spirometry.
- Hospitalized due to an acute exacerbation of COPD.
- Stable daytime arterial blood gas analysis showing PaCO₂ ≥ 50 mmHg, with hypoxemia.
- Already receiving or planned to receive long-term home non-invasive respiratory support.
- Capable of using a smartphone or tablet for video communication and has internet access.
- Willing to participate and provides written informed consent.
Exclusion Criteria:
- Concurrent severe pulmonary diseases (e.g., active tuberculosis, diffuse pulmonary fibrosis, advanced lung cancer).
- Chronic respiratory failure primarily caused by non-COPD conditions (e.g., neuromuscular disease, chest wall deformity, or severe obesity hypoventilation syndrome).
- Severe cognitive impairment or psychiatric illness that would prevent cooperation with remote management.
- Other severe systemic diseases with an expected survival of less than 1 year (e.g., advanced malignancy).
- Pregnant or lactating women.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Remote Intervention Group
Participants will receive home non-invasive respiratory support combined with active remote management.
|
Participants will receive home non-invasive respiratory support combined with active remote management.
This includes regular analysis of ventilation data, assessment of oxygenation status, risk prediction, and remote parameter adjustment by a respiratory therapist.
Participants will receive home non-invasive respiratory support with remote monitoring only.
No active intervention will be performed by the study team based on the data.
Patients will continue with standard care from their primary physician.
|
|
有源比较器:Monitoring Control Group
Participants will receive home non-invasive respiratory support with remote monitoring only.
|
Participants will receive home non-invasive respiratory support with remote monitoring only.
No active intervention will be performed by the study team based on the data.
Patients will continue with standard care from their primary physician.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Health-Related Quality of Life
大体时间:Baseline to 12 months
|
Measured by the change from baseline in the total score of the St. George's Respiratory Questionnaire (SGRQ) questionnaire at 12 months.
|
Baseline to 12 months
|
|
Number of COPD Exacerbations
大体时间:12 months
|
The number of acute exacerbations requiring antibiotics and/or systemic corticosteroids within 12 months.
|
12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in PaCO₂
大体时间:Baseline, 1, 3, 6, 12 months
|
The change from baseline in arterial partial pressure of carbon dioxide (PaCO₂) at 1, 3, 6, and 12 months.
|
Baseline, 1, 3, 6, 12 months
|
|
Changes in PaO₂
大体时间:Baseline, 1, 3, 6, 12 months
|
The change from baseline in arterial partial pressure of oxygen (PaO₂) at 1, 3, 6, and 12 months.
|
Baseline, 1, 3, 6, 12 months
|
|
Change in Dyspnea Severity (mMRC Score)
大体时间:Baseline, 1, 3, 6, 12 months
|
The change from baseline in the modified Medical Research Council (mMRC) dyspnea scale score to each follow up.
The scale ranges from 0 to 4, with higher scores indicating more severe dyspnea.
|
Baseline, 1, 3, 6, 12 months
|
|
Change in CAT Score
大体时间:Baseline, 1, 3, 6, and 12 months
|
The change from baseline in the total score of the COPD Assessment Test (CAT) at 1, 3, 6, and 12 months.
|
Baseline, 1, 3, 6, and 12 months
|
|
Change in SRI Score
大体时间:Time Frame: Baseline, 1, 3, 6, and 12 months
|
The change from baseline in the total score of the Severe Respiratory Insufficiency (SRI) questionnaire at 1, 3, 6, and 12 months.
|
Time Frame: Baseline, 1, 3, 6, and 12 months
|
|
Average daily usage of Non-invasive Ventilation
大体时间:Baseline, 1, 3, 6, and 12 months
|
Average daily usage of the non-invasive ventilation device (hours per day) recorded at 1, 3, 6, and 12 months.
|
Baseline, 1, 3, 6, and 12 months
|
|
Adherence-Percentage of days with usage greater than 4 hours
大体时间:Baseline, 1, 3, 6, and 12 months
|
Percentage of days with usage greater than 4 hours, recorded at 1, 3, 6, and 12 months.
|
Baseline, 1, 3, 6, and 12 months
|
|
Adverse Events
大体时间:Baseline, 1, 3, 6, and 12 months
|
The number and type of adverse events (AEs) and serious adverse events (SAEs) reported throughout the 12-month study duration.
|
Baseline, 1, 3, 6, and 12 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 20260597
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.